<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1), a latent <z:mp ids='MP_0001799'>viral</z:mp> protein consistently expressed in infected proliferating cells, is essentially required in trans to maintain EBV episomes in cells </plain></SENT>
<SENT sid="1" pm="."><plain>We constructed a mutant (mt) EBNA1 and examined whether it exerted dominant-negative effects on maintenance of the <z:mp ids='MP_0001799'>viral</z:mp> episome thereby leading to abrogation of EBV-infected <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell growth </plain></SENT>
<SENT sid="2" pm="."><plain>Using lymphocyte and epithelial cell lines converted with <z:chebi fb="0" ids="7507">neomycin</z:chebi>-resistant recombinant EBV (rEBV) as models, adenovirus vector-mediated transduction of mtEBNA1, but not LacZ, brought about rapid and striking reductions in rEBV-derived <z:mp ids='MP_0002169'>wild-type</z:mp> EBNA1 levels and <z:mp ids='MP_0001799'>viral</z:mp> genomic loads in converted lines of three major <z:mp ids='MP_0001799'>viral</z:mp> latencies </plain></SENT>
<SENT sid="3" pm="."><plain>This outcome was further validated at the single-cell level by cellular loss of G418 resistance and <z:mp ids='MP_0001799'>viral</z:mp> signals in situ </plain></SENT>
<SENT sid="4" pm="."><plain>The mtEBNA1 transduction significantly impaired growth of naturally EBV-harboring Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells in vitro and in vivo, largely in association with the eradication of <z:mp ids='MP_0001799'>viral</z:mp> episomes </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of mtEBNA1 per se caused no detectable cytotoxicity in EBV-uninfected cells </plain></SENT>
<SENT sid="6" pm="."><plain>These results indicate that mtEBNA1 can act as a dominant-negative effector that efficiently impedes the EBV-dependent malignant phenotypes in cells regardless of <z:mp ids='MP_0001799'>viral</z:mp> latency or tissue origin </plain></SENT>
<SENT sid="7" pm="."><plain>The mutant will afford an additional therapeutic strategy specifically targeting EBV-associated <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>